Patients with gout, especially those younger than 60 years, have an increased risk for benign prostatic hyperplasia (BPH), according to a study published online Dec. 26 in Diagnostics. Woo Jin Bang, ...
These new findings are important as α-blockers (ABs) are the most prescribed class of medications for patients with benign prostatic hyperplasia (BPH), but the cardiovascular safety profile of this ...
Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...
Inflating a drug-coated balloon in the prostate is the latest approach to treating a common cause of frequent or difficult urination in older men. More recently, researchers have developed various ...
Standard surgical treatments for benign prostatic hyperplasia (BPH) are safe for patients older than 75 years, Brazilian researchers concluded. Investigators at Hospital das Clinicas da Fuculdade de ...
Benign prostatic hyperplasia (BPH) and prostate cancer are two of the most common conditions that affect the prostate, a gland that’s part of the male reproductive system. Positioned below the bladder ...
LYON, France, October 1, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results